Neuropace Inc (NPCE) — Financial Flexibility Index
Neuropace Inc (NPCE) has a Financial Flexibility Index of -0.07x as of March 2026. Free cash flow of $-5.78 Million (operating CF $-5.90 Million minus capex $117.00K) represents 0% of total liabilities ($84.44 Million). Check NPCE strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Neuropace Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Neuropace Inc across 7 annual periods. See working capital to net assets of Neuropace Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Neuropace Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Neuropace Inc. For the full company profile including market capitalisation, see Neuropace Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.12x | $-10.67 Million | $-11.01 Million | $86.53 Million | ▲ +39.4% |
| 2024 | -0.20x | $-17.64 Million | $-17.95 Million | $86.63 Million | ▲ +9.3% |
| 2023 | -0.22x | $-19.53 Million | $-19.70 Million | $87.00 Million | ▲ +50.9% |
| 2022 | -0.46x | $-36.27 Million | $-36.87 Million | $79.33 Million | ▼ -13.5% |
| 2021 | -0.40x | $-24.19 Million | $-24.58 Million | $60.06 Million | ▼ -281.0% |
| 2020 | -0.11x | $-21.55 Million | $-21.61 Million | $203.78 Million | ▲ +35.2% |
| 2019 | -0.16x | $-24.56 Million | $-25.03 Million | $150.44 Million | — |